AbbVie’s board grew from 12 to 13 directors, and the new member is independent. The filing reports no change to its medicines or plans, so this does not change how we read the company.
The change adds another person to AbbVie’s board oversight. The filing does not report any change to its medicines, sales, or plans. The new director will receive the pay set for independent directors.
Follow AbbVie Inc. (ABBV) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ABBV